Literature DB >> 17701148

Exonucleolytic degradation of RNA by p53 protein in cytoplasm.

Mary Bakhanashvili1, Rachel Gedelovich, Shai Grinberg, Galia Rahav.   

Abstract

p53 in cytoplasm displays an intrinsic 3'-->5' exonuclease activity. To understand the significance of p53 exonuclease activity in cytoplasm, cytoplasmic extracts of various cell lines were examined for exonuclease activity with different single-stranded RNA (ssRNA) substrates. Using an in vitro RNA degradation assay, we observed in cytoplasmic extracts of LCC2 cells, expressing high levels of endogenous wtp53, an efficient 3'-->5' exonuclease activity with RNA substrates, removing the 3'-terminal nucleotides. Interestingly, RNA containing AU-rich sequences (ARE) is the permissive substrate for exonucleolytic degradation. Evidence that exonuclease function with RNA detected in cytoplasmic extracts is attributed to the p53 is supported by several facts: (1) this activity closely parallels with status and levels of endogenous cytoplasmic p53; (2) the endogenous exonuclease exerts identical RNA substrate specificity and excision profile characteristic for purified baculovirus-or bacterially-expressed wtp53s; (3) the exonuclease activity with ARE RNA is competed out by the presence of ss or double-stranded DNA substrate utilized by p53 protein in cytoplasm; (4) immunoprecipitation by specific anti-p53 antibodies markedly reduced the exonuclease activity with both RNA and DNA substrates; and (5) transfection of the wtp53, but not exonuclease-deficient mutant p53-R175H, into p53-null H1299 or HCT116 cells induced high levels of exonuclease activity with ARE RNA substrate in cytoplasm with characteristic excision profile. The efficient ARE RNA degradation correlates with the efficient binding of p53 to ARE RNA in cytoplasm. The possible role of p53 exonuclease activity in ARE-mRNA destabilization in cytoplasm, which may be important for expression of proteins that control cell growth and/or apoptosis is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701148     DOI: 10.1007/s00109-007-0247-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  38 in total

1.  Exonucleolytic proofreading by p53 protein.

Authors:  M Bakhanashvili
Journal:  Eur J Biochem       Date:  2001-04

2.  p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.

Authors:  M Bakhanashvili
Journal:  Oncogene       Date:  2001-11-15       Impact factor: 9.867

3.  Conformational phenotype of p53 is linked to nuclear translocation.

Authors:  S V Gaitonde; J R Riley; D Qiao; J D Martinez
Journal:  Oncogene       Date:  2000-08-17       Impact factor: 9.867

4.  A role for p53 in base excision repair.

Authors:  J Zhou; J Ahn; S H Wilson; C Prives
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

5.  Impaired interleukin-3 mRNA decay in autocrine mast cell tumors after transient calcium ionophore stimulation.

Authors:  H H Hirsch; V Backenstoss; C Moroni
Journal:  Growth Factors       Date:  1996       Impact factor: 2.511

6.  Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: mispair extension frequencies.

Authors:  M Bakhanashvili; A Hizi
Journal:  Biochemistry       Date:  1992-10-06       Impact factor: 3.162

7.  RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein.

Authors:  Mark T Worthington; Jared W Pelo; Muhammadreza A Sachedina; Joan L Applegate; Kristen O Arseneau; Theresa T Pizarro
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

8.  P53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Mary Bakhanashvili; Elena Novitsky; Gila Lilling; Gilia Rahav
Journal:  Oncogene       Date:  2004-09-09       Impact factor: 9.867

9.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

10.  p53-catalyzed annealing of complementary single-stranded nucleic acids.

Authors:  P Oberosler; P Hloch; U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  5 in total

1.  Kip3-ing kinetochores clustered.

Authors:  Ryoma Ohi
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

2.  p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements.

Authors:  Sanaz Derech-Haim; Yael Friedman; Amnon Hizi; Mary Bakhanashvili
Journal:  J Mol Med (Berl)       Date:  2020-02-04       Impact factor: 4.599

3.  p53 in the mitochondria, as a trans-acting protein, provides error-correction activities during the incorporation of non-canonical dUTP into DNA.

Authors:  Elad Bonda; Galia Rahav; Angelina Kaya; Mary Bakhanashvili
Journal:  Oncotarget       Date:  2016-11-08

Review 4.  Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.

Authors:  Joan Manils; Laura Marruecos; Concepció Soler
Journal:  Cells       Date:  2022-07-09       Impact factor: 7.666

5.  Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53.

Authors:  Tuck Seng Wong; Sridharan Rajagopalan; Fiona M Townsley; Stefan M Freund; Miriana Petrovich; David Loakes; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2008-12-09       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.